Hypofractionated radiotherapy with or without IGRT in prostate cancer: Preliminary report of acute toxicity - Abstract

S. Andrea Hospital, La Sapienza University of Rome, via di Grottarossa 1035, 00189 Rome Italy.


To evaluate the acute tolerance to hypofractionated schedule of patients with prostate cancer.

We treated 62 patients with intermediate risk prostate cancer. All patients were treated with a total dose of 43.8 Gy on seminal vesicles and 54.75 Gy on prostate, 3.65 Gy per fraction, three times a week for a total of 5 weeks. All patients underwent neoadjuvant, concomitant and adjuvant hormonal therapy. Thirty-six patients were submitted to image-guided radiation therapy (IGRT).

Median follow-up was 15 months (range 3-33 months). Toxicities during the treatment were: grade 1-2 gastrointestinal (GI) toxicity, 22.6%; grade 1-2 genitourinary (GU) toxicity, 51.6%. Toxicities 3 months after the end of the treatment were grade 1-2 GI 6.5%, grade 1-2 GU 9.7%. No statistical difference was observed comparing acute toxicity in patients treated with or without IGRT.

This study showed that the hypofractionation schedule used is well tolerated, with a low rate of acute grade 1-2 GI toxicity and without major grade (≥3) acute toxicity. Longer follow-up is needed to determine if this low rate of acute toxicity will be translated in a low rate of late toxicity.

Written by:
Valeriani M, Monaco F, Osti MF, DE Sanctis V, Minniti G, Enrici RM.   Are you the author?

Reference: Anticancer Res. 2011 Oct;31(10):3555-8.

PubMed Abstract
PMID: 21965777

UroToday.com Prostate Cancer Section